Abstract:Brain tumors are among the most lethal tumors. Glioblastoma, the most frequent primary brain tumor in adults, has a median survival time of approximately 15 months after diagnosis or a five-year survival rate of 10%; the recurrence rate is nearly 90%. Unfortunately, this prognosis has not improved for several decades. The lack of progress in the treatment of brain tumors has been attributed to their high rate of primary therapy resistance. Challenges such as pronounced inter-patient variability, intratumoral heterogeneity, and drug delivery across the blood–brain barrier hinder progress. A comprehensive, multiscale understanding of the disease, from the molecular to the whole tumor level, is needed to address the intratumor heterogeneity resulting from the coexistence of a diversity of neoplastic and non-neoplastic cell types in the tumor tissue. By contrast, inter-patient variability must be addressed by subtyping brain tumors to stratify patients and identify the best-matched drug(s) and therapies for a particular patient or cohort of patients. Accomplishing these diverse tasks will require a new framework, one involving a systems perspective in assessing the immense complexity of brain tumors. This would in turn entail a shift in how clinical medicine interfaces with the rapidly advancing high-throughput (HTP) technologies that have enabled the omics-scale profiling of molecular features of brain tumors from the single-cell to the tissue level. However, several gaps must be closed before such a framework can fulfill the promise of precision and personalized medicine for brain tumors. Ultimately, the goal is to integrate seamlessly multiscale systems analyses of patient tumors and clinical medicine. Accomplishing this goal would facilitate the rational design of therapeutic strategies matched to the characteristics of patients and their tumors. Here, we discuss some of the technologies, methodologies, and computational tools that will facilitate the realization of this vision to practice.

Recent Advances in the Diagnosis and Treatment of Brain Tumors

Neurosurgery for Brain Tumors: Update on Recent Technical Advances

Advances in the Development of New Drugs and Treatment Targets for Brain Cancers

Top advances of the year: Neuro-oncology

Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain Tumors

Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment

Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance

Recent Advances in Brain Tumor-Targeted Nano-Drug Delivery Systems

Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions

Artificial Intelligence and Precision Medicine: A New Frontier for the Treatment of Brain Tumors

The Current Situation and Advances in the Whole Brain Radiation Therapy for Newly-diagnosed Brain Metastases

Revolutionizing Brain Tumor Care: Emerging Technologies and Strategies

Targeted Brain Tumor Treatment-Current Perspectives

Brain Tumor at Diagnosis: From Cognition and Behavior to Quality of Life

Progress on the Diagnosis and Evaluation of Brain Tumors

Nanomaterials for Diagnosis and Treatment of Brain Cancer: Recent Updates

Advances in Cranial Surgery

Review of Current Principles of the Diagnosis and Management of Brain Metastases

A Systems Approach to Brain Tumor Treatment

Introduction to the Special Issue on "Role of Novel Imaging Technique in Brain Tumors"